Page last updated: 2024-08-25

chitosan and LCIS, Lobular Carcinoma In Situ

chitosan has been researched along with LCIS, Lobular Carcinoma In Situ in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bessone, F; Cavalli, R; Cavallo, F; Giribaldi, G; Guiot, C; Gulino, GR; Khadjavi, A; Minero, VG; Panariti, A; Prato, M; Quaglino, E; Rivolta, I; Stura, I1

Other Studies

1 other study(ies) available for chitosan and LCIS, Lobular Carcinoma In Situ

ArticleYear
'In Vitro', 'In Vivo' and 'In Silico' Investigation of the Anticancer Effectiveness of Oxygen-Loaded Chitosan-Shelled Nanodroplets as Potential Drug Vector.
    Pharmaceutical research, 2018, Feb-26, Volume: 35, Issue:4

    Topics: Animals; Antineoplastic Agents; Breast Carcinoma In Situ; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Computer Simulation; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Fluorocarbons; Humans; Mice; Mice, Inbred BALB C; Models, Biological; Nanoparticles; Oxygen

2018